SFLT1 MEDIATED PRETERM PREECLAMPSIA

Clinical trials for SFLT1 MEDIATED PRETERM PREECLAMPSIA explained in plain language.

Never miss a new study

Get alerted when new SFLT1 MEDIATED PRETERM PREECLAMPSIA trials appear

Sign up with your email to follow new studies for SFLT1 MEDIATED PRETERM PREECLAMPSIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New shot tested to help moms with dangerous pregnancy condition

Disease control Recruiting now

This early-stage study is testing a new injection called CBP-4888 in pregnant women hospitalized with preterm preeclampsia, a serious blood pressure condition. The main goal is to find a safe and tolerable dose and to understand how the drug moves through the body. Participants w…

Matched conditions: SFLT1 MEDIATED PRETERM PREECLAMPSIA

Phase: PHASE1 • Sponsor: Comanche Biopharma • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

SFLT1 MEDIATED PRETERM PREECLAMPSIA

Get alerted when new SFLT1 MEDIATED PRETERM PREECLAMPSIA trials appear

New shot tested to help moms with dangerous pregnancy condition